TrialScientific reports2019

Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.

Magdalena Gómez-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.